M
Michael J. Mack
Researcher at Scott & White Hospital
Publications - 634
Citations - 36680
Michael J. Mack is an academic researcher from Scott & White Hospital. The author has contributed to research in topics: Valve replacement & Medicine. The author has an hindex of 89, co-authored 519 publications receiving 28877 citations. Previous affiliations of Michael J. Mack include Baylor University Medical Center & Medical City Dallas Hospital.
Papers
More filters
Journal ArticleDOI
Impact of peripheral arterial disease on outcomes after transcatheter mitral valve repair in heart failure: from the coapt trial
Bahira Shahim,David J. Cohen,Ori Ben-Yehuda,Björn Redfors,Saibal Kar,Kar,D. Scott Lim,Suzanne V. Arnold,Yanru Li,JoAnn Lindenfeld,William T. Abraham,Michael J. Mack,Gregg W. Stone +12 more
Journal ArticleDOI
A-3 | Outcomes of the REDUCE-AKI Initiative: A Multi-Disciplinary Approach Addressing Acute Kidney Injury Post Percutaneous Coronary Intervention
Karim Al-Azizi,Ghadi Moubarak,Molly Szerlip,Austin Kluis,LG Foster,Sibi Thomas,Chadi Dib,Sameh Sayfo,Jai Varma,Imran Baig,Róbert Farkas,S. Biederman,William H. Ryan,J. Michael DiMaio,Michael J. Mack,Srinivasa Potluri +15 more
Journal ArticleDOI
Pacemaker implantation associated with tricuspid repair in the setting of mitral valve surgery: Insights from a Cardiothoracic Surgical Trials Network randomized trial.
Gorav Ailawadi,Pierre Voisine,Samantha Raymond,Annetine C. Gelijns,Alan J. Moskowitz,Volkmar Falk,Jessica Overbey,Michael W.A. Chu,Michael J. Mack,Michael E. Bowdish,Markus Krane,Babatunde A. Yerokun,Lenard Conradi,Steven F. Bolling,Marissa A. Miller,Wendy C. Taddei-Peters,Kathleen N. Fenton,Neal Jeffries,Robert S. Kramer,Arnar Geirsson,Ellen Moquete,Karen O'Sullivan,Jonathan Hupf,Judy Hung,Friedhelm Beyersdorf,Emilia Bagiella,James S. Gammie,Patrick T. O'Gara,Alexander Iribarne,Michael A. Borger,Marc Gillinov +30 more
TL;DR: In this paper , the authors found that tricuspid annuloplastic (TA) during mitral valve surgery (MVS) for degenerative mitral regurgitation and moderate or less TR reduced the composite rate of death, reoperation for TR, or TR progression at 2 years, but this benefit was counterbalanced by an increase in implantation of permanent pacemakers.